{"entity":{"type":"insider","cik":"0001520374","url":"/insider/0001520374","json_url":"/insider/0001520374.json","name":"Berholtz Randy","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":4,"n_filings":1,"first":"2017-11-27","last":"2017-11-27","span_basis":"filed_date"},"name_variants":[{"name":"Berholtz Randy","source":"filing","n_filings":1,"first_seen":"2017-11-27","last_seen":"2017-11-27"}],"transactions":[{"id":4799342,"accession":"0001415889-17-001860","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-17-001860","line_url":"/filing/0001415889-17-001860#line-4","is_derivative":false,"issuer_cik":"0001411879","issuer_name":"INNOVUS PHARMACEUTICALS, INC.","issuer_ticker":"INNV","issuer_name_source":null,"issuer_url":"/issuer/0001411879","owner_cik":"0001520374","owner_name":"Berholtz Randy","owner_url":"/insider/0001520374","role":"Officer (EVP, CORPORATE DEVELOPMENT)","officer_title":"EVP, CORPORATE DEVELOPMENT","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4990.0,"shares_display":"4,990","price_per_share":0.0968,"price_display":"0.10","price_state":"stated","total_value":483.032,"total_display":"483.03","shares_owned_after":14880.0,"shares_owned_after_display":"14,880","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-22","filed_date":"2017-11-27","scope":"insider"},{"id":4799338,"accession":"0001415889-17-001860","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-17-001860","line_url":"/filing/0001415889-17-001860#line-3","is_derivative":false,"issuer_cik":"0001411879","issuer_name":"INNOVUS PHARMACEUTICALS, INC.","issuer_ticker":"INNV","issuer_name_source":null,"issuer_url":"/issuer/0001411879","owner_cik":"0001520374","owner_name":"Berholtz Randy","owner_url":"/insider/0001520374","role":"Officer (EVP, CORPORATE DEVELOPMENT)","officer_title":"EVP, CORPORATE DEVELOPMENT","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4990.0,"shares_display":"4,990","price_per_share":0.0968,"price_display":"0.10","price_state":"stated","total_value":483.032,"total_display":"483.03","shares_owned_after":4990.0,"shares_owned_after_display":"4,990","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-22","filed_date":"2017-11-27","scope":"insider"},{"id":4799335,"accession":"0001415889-17-001860","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-17-001860","line_url":"/filing/0001415889-17-001860#line-2","is_derivative":false,"issuer_cik":"0001411879","issuer_name":"INNOVUS PHARMACEUTICALS, INC.","issuer_ticker":"INNV","issuer_name_source":null,"issuer_url":"/issuer/0001411879","owner_cik":"0001520374","owner_name":"Berholtz Randy","owner_url":"/insider/0001520374","role":"Officer (EVP, CORPORATE DEVELOPMENT)","officer_title":"EVP, CORPORATE DEVELOPMENT","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4900.0,"shares_display":"4,900","price_per_share":0.0967,"price_display":"0.10","price_state":"stated","total_value":473.83,"total_display":"473.83","shares_owned_after":9890.0,"shares_owned_after_display":"9,890","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-22","filed_date":"2017-11-27","scope":"insider"},{"id":4799331,"accession":"0001415889-17-001860","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-17-001860","line_url":"/filing/0001415889-17-001860#line-1","is_derivative":false,"issuer_cik":"0001411879","issuer_name":"INNOVUS PHARMACEUTICALS, INC.","issuer_ticker":"INNV","issuer_name_source":null,"issuer_url":"/issuer/0001411879","owner_cik":"0001520374","owner_name":"Berholtz Randy","owner_url":"/insider/0001520374","role":"Officer (EVP, CORPORATE DEVELOPMENT)","officer_title":"EVP, CORPORATE DEVELOPMENT","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":0.0954,"price_display":"0.10","price_state":"stated","total_value":190.8,"total_display":"190.80","shares_owned_after":16880.0,"shares_owned_after_display":"16,880","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-22","filed_date":"2017-11-27","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":4,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":4,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":4},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001411879","name":"INNOVUS PHARMACEUTICALS, INC.","url":"/issuer/0001411879","role":"Officer (EVP, CORPORATE DEVELOPMENT)","n_filings":1,"first_seen":"2017-11-27","last_seen":"2017-11-27"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001520374","retrieved_at":"2026-08-22T03:46:57+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}